To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Triamcinolone has a rapid but short lasting effect in idiopathic trigger finger

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Author Verified
Ace Report Cover
March 2013

Triamcinolone has a rapid but short lasting effect in idiopathic trigger finger

Vol: 2| Issue: 2| Number:227| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:1

A prospective randomized controlled trial of injection of dexamethasone versus triamcinolone for idiopathic trigger finger

J Hand Surg Am. 2008 Apr;33(4):516-22; discussion 523-4.

Contributing Authors:
D Ring S Lozano-Calderón R Shin P Bastian C Mudgal J Jupiter

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

84 patients (>18 years) with idiopathic trigger finger were randomized to receive either dexamethasone or triamcinolone injection, to determine which treatment was better in resolving triggering symptoms. Although no statistically significant differences between the 2 treatments were seen at 3 months after injection, a trend was noticed suggesting that triamcinolone had a rapid but short lasting e...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue